QT
ODT

Quantbot Technologies’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History

Quantbot Technologies’s Portfolio ODT Stock Details ODT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,300
Closed -$6K – 2075
2021
Q3 		$6K Buy
+2,300
New +$7.65K ﹤0.01% 1407
2020
Q4 		– Sell
-158
Closed -$2K – 1821
2020
Q3 		$2K Buy
+158
New +$4.48K ﹤0.01% 1235

Other funds holding ODT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

Quantbot Technologies's ODT Position: Q4 2021 in Review

Quantbot Technologies sold out of Odonate Therapeutics, Inc. Common Stock (ODT) in Q4 2021, closing a stake of 2,300 shares — an estimated $6K sold.

Quantbot Technologies first reported a position in ODT in Q3 2020 and held it in 2 quarters. The position peaked at $6K in Q3 2021. 50 funds tracked by Wall St. Rank hold ODT as of Q4 2021.

  • Quantbot Technologies reported no remaining Odonate Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Quantbot Technologies sold 2,300 Odonate Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $6K.
  • Quantbot Technologies first reported a position in Odonate Therapeutics, Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Quantbot Technologies's Odonate Therapeutics, Inc. Common Stock position peaked at $6K in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Odonate Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Quantbot Technologies's 13F filing for Q4 2021, filed 11 Feb 2022.